Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area dna damage topoisomerase ii'

Search results for: 'research area dna damage topoisomerase ii'

Items 21-30 of 78

Page
per page
  1. Lomeguatrib
    A1912 Lomeguatrib
    Target: O6-methylguanine-DNA-methyl-transferase (MGMT)
    Summary: MGMT inhibitor
      ≥50 mg/mL
  2. Mitoxantrone HCl
    B2114 Mitoxantrone HCl
    Target: Pim|Topoisomerases|USP|HIV Integrases
    Summary: Topoisomerase II inhibitor, anti-neoplastic drug
      insoluble in EtOH; ≥51.53 mg/mL
  3. Clinafloxacin CI96 AM1091
    A8400 Clinafloxacin CI96 AM1091
    Target: Topoisomerases
    Summary: Topoisomerase inhibitor
      insoluble in H2O; insoluble in EtOH; ≥3.66 mg/mL
  4. Temozolomide
    B1399 Temozolomide
    Summary: DNA methylating, chemotherapeutic agent
      insoluble in EtOH; insoluble in H2O; ≥29.61 mg/mL
  5. DMAT
    A3368 DMAT
     2 Citation
    Target: Pim|CK2|HIPK2|HIPK3
    Summary: CK2 inhibitor,potent and selective
      ≥23.85 mg/mL
  6. Nedaplatin
    B1986 Nedaplatin
    Summary: DNA synthesis inhibitor
      insoluble in DMSO; insoluble in EtOH; ≥9.8 mg/mL
  7. LY2109761
    A8464 LY2109761
     4 Citation
    Summary: TβRI/II kinase inhibitor
      ≥22.1 mg/mL
  8. KN-62
    A8180 KN-62
    Target: Ca2 /calmodulin-dependent protein kinases (CaMKs)|P2X Receptors
    Summary: CaM kinase II inhibitor
      ≥36.1 mg/mL
  9. RepSox
    A3754 RepSox
    Summary: ALK5 inhibitor,potent and selective
      insoluble in H2O; ≥14.35 mg/mL
  10. Z-DEVD-FMK
    A1920 Z-DEVD-FMK
     12 Citation
    Target: Caspases
    Summary: Caspase-3 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥60 mg/mL

Items 21-30 of 78

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 73item
  2. Natural Products 1 item
  3. Peptides 1 item
  4. Peptides & Proteins 1 item
Reversibility
  1. Reversible 5item
  2. Irreversible 1 item
Target
  1. Caspases 1 item
  2. Cyclin-Dependent Kinases 1 item
  3. Cathepsins 1 item
  4. Histone Deacetylases (HDACs) 2item
  5. Akt 1 item
  6. PI3K 4item
  7. mTOR 3item
  8. AP-1 1 item
  9. Myosin II ATPases 1 item
  10. Chk 2item
  11. Eph Receptors 1 item
  12. Thymidylate Synthase 1 item
  13. Pim 2item
  14. Voltage-gated Sodium (NaV) Channels 1 item
  15. PP1 1 item
  16. PP2A 1 item
  17. MET 1 item
  18. Trk Receptors 1 item
  19. STAT 3item
  20. ROCK 1 item
  21. JAK 1 item
  22. DNA-PK 5item
  23. Angiotensin AT2 Receptors 3item
  24. CFTR 1 item
  25. Topoisomerases 9item
  26. DNA Methyltransferases 3item
  27. Calpains 1 item
  28. Ubiquitin-specific proteases 1 item
  29. Ca2 /calmodulin-dependent protein kinases (CaMKs) 5item
  30. USP 1 item
  31. 5-HT2 Receptors 1 item
  32. D1 and D5 Receptors 1 item
  33. D2 Receptors 1 item
  34. D3 Receptors 1 item
  35. 5-HT1 Receptors 1 item
  36. 5-HT7 Receptors 1 item
  37. Fatty-acid-binding proteins (FABPs) 1 item
  38. ATM/ATR 2item
  39. CK2 1 item
  40. HIPK2 1 item
  41. HIPK3 1 item
  42. HIV Integrases 1 item
  43. P2X Receptors 1 item
  44. Carbonic Anhydrases 1 item
  45. BLM 1 item
  46. HSV 1 item
  47. Synthases/Synthetases 2item
  48. MAGL 1 item
  49. RNA Polymerases 1 item
  50. CMV 1 item
  51. Angiotensin AT1 Receptors 2item
  52. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  53. Cytidine deaminases 1 item
  54. PP4 1 item
  55. Dipeptidyl-peptidase II 1 item
  56. HCV polymerase 1 item
  57. ATM 1 item
  58. Sirtuin 1 item
Reported Experiments
  1. Animal Experiments 69item
  2. Cell Experiments 48item
Related Disease
  1. Acute Myelogenous Leukemia 2item
  2. Acute Myeloid Leukemia 2item
  3. Acute Renal Failure 1 item
  4. Adrenocortical Carcinoma 1 item
  5. Bladder Cancer 2item
  6. Bladder Carcinoma 2item
  7. Bladder Diseases 1 item
  8. Breast Cancer 12item
  9. Cancer 48item
  10. Cervical Cancer 2item
  11. Cholangiocarcinoma 1 item
  12. Colon Cancer 9item
  13. Colorectal Cancer 5item
  14. Diabetes 1 item
  15. Glioblastoma 4item
  16. Glioma 1 item
  17. Hepatitis C 1 item
  18. Hepatocellular Carcinoma 2item
  19. HIV Infections 1 item
  20. Inflammatory Diseases 2item
  21. Leukemia 4item
  22. Lung Cancer 4item
  23. Lymphoma 5item
  24. Melanoma 5item
  25. Multiple Myeloma 2item
  26. Myeloma 2item
  27. Neuroblastoma 1 item
  28. Non-small Cell Lung Carcinoma 1 item
  29. Ovarian Cancer 8item
  30. Pancreatic Cancer 5item
  31. Prostate Cancer 6item
  32. Renal Cell Carcinoma 1 item
  33. Sarcoma 1 item
  34. Schizophrenia 1 item
  35. Squamous Cell Carcinoma 1 item
  36. Testicular Cancer 2item
  37. Type 2 Diabetes 2item